- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02173353
Feasibility of Using Ultrasound to Track Respiration Motion
October 7, 2022 updated by: An Tai, Medical College of Wisconsin
The purpose of this study is to evaluate the effectiveness of using ultrasound to image and track pancreas/duodenum motion during radiation therapy treatment delivery.
Also develop a workflow and process to allow the final ultrasound system to be used routinely by radiation therapists.
Study Overview
Detailed Description
- Acquire 2D and 3D ultrasound images for 5 pancreatic cancer patients using the existing Clarity system with a hand-held probe. The visibility of pancreas, duodenum, and other organs will be evaluated. Based on this image acquisition experience, design and construct stands to hold the ultrasound probe. Issues to be considered in the design include (i) avoiding the stand and probe blocking radiation beams, (ii) avoiding ultrasound going through the ribs, (iii) minimizing the effect of respiration motion. Also explore building the probe into the immobilization device (e.g., Alpha cradle) or using robotic arm.
- Acquire ultrasound images for 20 patients with pancreatic cancer treated in the Department of Radiation Oncology department using the tools developed in Aim 1. As the standard practice, the 4 dimensional CT (4DCT) and 4 dimensional (4D) morphological and physiological MRI (T1, T2, apparent diffusion coefficient, DWI) will be acquired for treatment planning, and a respiration-gated CT will be acquired immediately before the delivery of each fraction using an in-room CT or cone-beam CT for patient positioning. The ultrasound images may be acquired during initial simulation immediately before or after the planning 4DCT and the daily gated CT, and during the treatment delivery in 2D, 3D and/or 4D modes. All raw ultrasound data will be stored.
- Process ultrasound data acquired above to evaluate the effectiveness of using ultrasound to image and to track pancreas/duodenum motion during the treatment delivery. The images will be processed to visualize pancreas and/or surrogates, such as the boundary between pancreas and duodenum, infusion catheter. To improve the visible appearance, elastography will be explored by processing the raw data collected in Aim 2. Existing software will be used, and may be modified if necessary, to segment and to register ultrasound with CT. A tool the investigators previous develop for multimodality registration will be used to register ultrasound with MRI. Anatomic markers, such as the boundary between pancreas head and duodenum, stent, infusion catheter, may be used for registration and/or motion tracking.
- Develop/modify workflow and process to allow the final system to be used routinely by radiation therapists. If necessary, user-friendly software tools will be developed/incorporated in the final system.
- Explore the use of Doppler mode for tissue characterization and the potential of using it to image radiation effects.
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Froedtert Hospital & the Medical College of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients who will receive standard radiation therapy for pancreas cancer.
Description
Inclusion Criteria:
- Patients who will receive standard radiation therapy for pancreas cancer
Exclusion Criteria:
- Patients who will receive standard radiation therapy for sites other than pancreas cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pancreas cancer
Develope a stand, cradle or robotic arm to hold the ultrasound probe, to obtain an ultrasound just before a standard radiation therapy treatment is given.
|
Ultrasound to be done just before standard radiation therapy treatment
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the use of ultrasound to detect motion of pancrease and surrounding structures
Time Frame: 5 years from the date of enrollment
|
Design and construct stands to hold the ultrasound probe.
Issues to be considered in the design include (i) avoiding the stand and probe blocking radiation beams, (ii) avoiding ultrasound going through the ribs, (iii) minimizing the effect of respiration motion.
Explore building the probe into the immobilization device (e.g., Alpha cradle) or using robotic arm.
|
5 years from the date of enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of ultrasound imaging for Pancreas
Time Frame: 3 years from the date of enrollment
|
Acquire ultrasound images for 20 patients with the immobilization device (e.g., Alpha cradle) or using a robotic arm.
|
3 years from the date of enrollment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess organ motion and compare in conjunction with magnetic resonance imaging or CT
Time Frame: 5 years from the date of enrollment
|
Process ultrasound data acquired to evaluate the effectiveness of using ultrasound to image and to track pancreas/duodenum motion during the treatment delivery.
Develop/modify workflow and process to allow the final system to be used routinely by radiation therapists.
If necessary, user-friendly software tools will be developed/incorporated in the final system.
Explore the use of Doppler mode for tissue characterization and the potential of using it to image radiation effects.
|
5 years from the date of enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: An Tai, PhD, Medical College of Wisconsin
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2014
Primary Completion (ACTUAL)
November 1, 2020
Study Completion (ACTUAL)
November 1, 2020
Study Registration Dates
First Submitted
June 17, 2014
First Submitted That Met QC Criteria
June 20, 2014
First Posted (ESTIMATE)
June 25, 2014
Study Record Updates
Last Update Posted (ACTUAL)
October 12, 2022
Last Update Submitted That Met QC Criteria
October 7, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO00020659
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Neoplasms
-
Revolution Medicines, Inc.RecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Cancer Metastatic | Pancreatic Adenosquamous Carcinoma | Pancreatic Ductal Adenocarcinoma (PDAC) | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Pancreatic Adenocarcinoma MetastaticUnited States
-
Revolution Medicines, Inc.AvailablePancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Cancer Metastatic | Pancreatic Adenosquamous Carcinoma | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Pancreatic Adenocarcinoma Metastatic | Metastatic Pancreas Adenocarcinoma
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsUnited States, Japan, South Korea
-
Revolution Medicines, Inc.RecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Cancer Metastatic | Pancreatic Adenosquamous Carcinoma | Pancreatic Ductal Adenocarcinoma (PDAC) | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Pancreatic Adenocarcinoma MetastaticUnited States
-
Revolution Medicines, Inc.RecruitingPancreatic Cancer | Resected Pancreatic Adenocarcinoma | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic Ductal Adenocarcinoma (PDAC)United States, Puerto Rico, United Kingdom
-
PanTher TherapeuticsRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic AdenocarcinomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of California, IrvineRecruitingPancreatic Cancer | Pancreatic Cancer MetastaticUnited States
-
Astellas Pharma Global Development, Inc.RecruitingPancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States, Japan
-
National Cancer Institute (NCI)Not yet recruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal Adenocarcinoma
Clinical Trials on Ultrasound
-
Ahram Canadian UniversityCompletedCarpal Tunnel Syndrome | Median Neuropathy, Carpal TunnelEgypt
-
Eskisehir Osmangazi UniversityCompletedCarpal Tunnel Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Cairo UniversityUnknown
-
Ohio State University Comprehensive Cancer CenterWithdrawn
-
Oregon Health and Science UniversityRecruiting
-
Yale UniversityCompletedPneumonia | Pulmonary Edema | DyspneaUnited States
-
Odense University HospitalEnrolling by invitationThoracic Ultrasound | Fibrosing Interstitial Lung DiseasesDenmark
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedShoulder Impingement Syndrome | Shoulder PainTurkey
-
John PelleritoGeneral ElectricActive, not recruiting